July 5, 2021: Israel has recorded a steep drop in the efficacy rate of the Pfizer Inc.-BioNTech SE in preventing coronavirus infections, due to the spread of the delta variant and the easing of government restrictions, Ynet news website reported citing Health Ministry data.
At the same time, the decline in protection against serious cases and hospitalization is considerably milder, the website said. There was no immediate comment from the ministry.
Statistics show that between May 2 and June 5, the vaccine efficacy rate was 94.3%. From June 6, five days after the government lifted the ban on corona virus, by early July, the rate had dropped to 64 percent. A similar decline in protection against the symptoms of the corona virus was recorded, the report said.
At the same time, protection against hospitalization and serious illness remained strong. From May 2 to June 5, the efficacy rate in hospital admissions was 98.2%, compared to 93% from June 6 to July 3. . Annette said the figures are in line with ministry figures, which show that many of the new cases are among those who have been vaccinated, while the number of serious cases is growing slowly. Last Friday, 55% of newly infected people were vaccinated against polio. As of July 4, there were 35 serious cases of the coronavirus in Israel, compared to 21 on June 19.
The government is considering reinstating additional restrictions on the corona virus following the restoration of the mandate to wear masks indoors in public places. Authorities are also discussing whether to recommend a third dose of the vaccine, the report said. Pfizer CEO Albert Bourla says people will need a third dose of Covid 19 within 12 months of being fully vaccinated. Israel had one of the most effective coronavirus injection drives in the world.
Approximately 57% of the general population is fully vaccinated, including 88% of the population over 50 years of age. This group is considered to be at high risk of serious cases.
Stay tuned to BaaghiTV for latest news and Updates!
